Finally, other studies with DT2 [20] and PCOS [28] reported that these patients have higher levels of myonectin than controls (-values as mean ± standard deviation- 82.3 ± 47.6 vs. 45.2 ± 23.5 ng·mL−1, and -values as mean (Q3-Q1)- 96.3 (50.2) vs. 55.6 (20.4) ng·mL−1, respectively). Here, ERFE is linked to polycystic ovary syndrome.